Celonic Group, a biologics CDMO, has signed a multi-year commercial manufacturing agreement with LINDIS Biotech for the ...

Ivor Elrifi, CEO of Tiziana Life Sciences, commented, “Partnering with Renaissance is a significant milestone in our mission ...

Dr. Srinivas Rao, Co-Founder and CEO of atai, added, “This agreement strengthens our DMT patent portfolio and enables us to ...

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel ...

Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, has ...

Paul Owen has been appointed as Chief Executive Officer of YourBio Health, a pioneer in remote blood collection technology, ...

ACG Capsules, a capsule manufacturer, has introduced fully vegan printed capsules.

Asahi Kasei Bioprocess America Inc. (AKBA), a provider of advanced filtration and fluid management solutions for the ...

Eleva, a pioneer in unlocking difficult-to-produce biologics, has appointed Dr. Martin Bauer, MD, as its new Chief Medical ...

Brexogen, a biotechnology company specializing in exosome-based therapeutics, has signed a technology transfer and licensing ...

As a biologics CDMO focused on developing and manufacturing recombinant protein products using mammalian cell culture ...

The U.S. Food and Drug Administration (FDA) has accepted for filing PTC Therapeutics’ New Drug Application (NDA) for ...